Business Responsibility and Sustainability Report for FY 2024-25

Copy of Newspaper Intimation relating to Annual General Meeting and e-voting related information.

Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2025 ,inter alia, to consider and approve standalone and consolidated financial results for the quarter ended June 30, 2025

Shareholder Meeting- AGM on August 19, 2025.

Resignation of Chief Financial Officer (CFO) and Key Managerial Personnel of the Company.

Please find attached herewith intimation regarding further investment by way of acquisition of equity shares of Wholly Owned Subsidiary.

Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a pdf copy of the Notice of the 89th AGM and Annual Report 2024-25 of our Company for the financial year ended 31 March 2025 for your reference with a request to please disseminate them on your website for information of all the Members and Investors of our Company. The Annual Report 2024-25 and Notice of the 89th Annual General Meeting are also uploaded on the Company''s website at www.lindeindia.in. You are requested to kindly take the above information on record.

NEWSPAPER PUBLICATION

Earnings Call for 2nd quarter ended June 30, 2025